FOSTEC & Company advises Finexx on the acquisition of BeLive by executing a commercial due diligence

With the acquisition of BeLive, BioneXX Holding strengthens its international expansion. In the context of a commercial due diligence, the Stuttgart-based strategy consulting boutique FOSTEC & Company advised FINEXX GmbH.

In August, the Stuttgart-based holding company BioneXX successfully expanded its innovation power in the nutritional supplements industry with the acquisition of the US-based nutritional supplements manufacturer BeLive. Founded in 2017, BeLive had already increased its turnover by 165 percent last year and is a top seller on the Amazon marketplace with two products for Nutraceutical Gummies. BeLive’s products are designed to satisfy needs for minerals and trace elements. As the market-leading holding company for certified organic & biological nutritional supplements, BioneXX is now planning to expand the trend to the German market and add four new products to its portfolio.

With this acquisition, the shareholder FINEXX funds the fourth investment of BioneXX and the second investment with the support of the strategy consulting boutique FOSTEC & Company. As one of the fastest growing companies in Europe, FOSTEC & Company advised the client FINEXX on the transaction providing a commercial due diligence and a comprehensive analysis of the digital value chain and e-commerce activities. “We have been able to achieve gratifying growth within the BioneXX Group over the past two years. The analyses within the framework of the CDD as well as the developed growth strategy of FOSTEC & Company have supported us significantly. This has enabled us to expand BioneXX as an international competitor, to gain a sustainable foothold in the USA, and to minimize risks during the transaction,” says Matthias Heining, Managing Director of FINEXX GmbH, regarding the cooperation with FOSTEC & Company.